JP Morgan Upgrades RXO to Neutral, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 92.3%

Neg 0% Neu 0% Pos 92.3%

JP Morgan analyst Brian Ossenbeck upgrades RXO (NYSE:RXO) from Underweight to Neutral and raises the price target from $22 to $30.